Montse Sanchez Cespedes (orcid.org/0000-0002-6045-5627)
机构: Josep Carreras Leukemia Research Institute-IJC
主页: orcid.org
每年引用次数
引用次数
引用: 25,676
H-指数: 65
I10-指数 : 103
出版物: 193
The tumour suppressor and chromatin‐remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer
Octavio A. Romero , Fernando Setien , Sam John , Pol Gimenez‐Xavier
Embo Molecular Medicine 4 ( 7) 603 -616
53
2012
Epigenetic disruption of cadherin-11 in human cancer metastasis
F. Javier Carmona , Alberto Villanueva , August Vidal , Clara Muñoz
The Journal of Pathology 228 ( 2) 230 -240
48
2012
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
Joan Frigola , Alejandro Navarro , Caterina Carbonell , Ana Callejo
Molecular Oncology 15 ( 4) 887 -900
1
2021
Prognostic value of KIT expression in small cell lung cancer.
Ana López-Martin , Claudio Ballestín , Rocío Garcia-Carbonero , Angel Castaño
Lung Cancer 56 ( 3) 405 -413
36
2007
High frequency of mitochondria DNA mutations in breast cancer: potential application for cancer detection
P Parrella , Y Xiao , M Fliss , M SANCHEZ-CESPEDES
CANCER RESEARCH 61 7623 -7626
2001
Experimental Studies-Transgenic Mice Expressing Constitutively Active Akt in Oral Epithelium Validate KLFA as a Potential Biomarker of Head and Neck Squamous Cell Carcinoma.
M Moral , C Segrelles , AB Martinezcruz , C Lorz
In vivo 23 ( 5) 653 -653
2009
UbcH10 may be a useful tool in the prognosis of lung carcinomas
Claudio Bellevicine , M Berlingieri , M Sanchez Cespedes , P Pallante
2009
Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification.
B Angulo , A Suarez‐Gauthier , F Lopez‐Rios , PP Medina
The Journal of Pathology 214 ( 3) 347 -356
88
2008
Analysis of the molecular expression profile of non small cell lung carcinoma associated to chronic obstructive pulmonary disease
Ricardo Garcia-Lujan , Esther Conde-Gallego , Fernando Lopez-Ríos , Jose Luis Martin de Nicolas
Histology and Histopathology 24 ( 4) 417 -423
2009
Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.
Isaac Almendros , Gemma Fuster Orellana , Jordi Alcaraz Casademunt , Abel Gomez-Caro
Oncotarget 7 ( 50) 82324 -82337
10
2016
Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells
Pol Gimenez-Xavier , Eva Pros , Ester Bonastre , Sebastian Moran
Molecular Cancer Therapeutics 16 ( 7) 1366 -1376
16
2017
Abstract IA02: Dissection of the BRG1 and MYC/MAX biological connection and its use in lung cancer therapeutics
Montse Sanchez-Cespedes
Molecular Cancer Research 13
2015
Abstract A35: MAX inactivation in small cell lung cancer disrupts the MYC-SWI/SNF programs and is synthetic lethal with BRG1
Manuel Torres-Diz , Octavio A. Romero , Eva Pros , Suvi Savola
Molecular Cancer Research 13
2015
Determinants of immunological evasion and immunocheckpoint inhibition response in non-small cell lung cancer: the genetic front.
Maria Saigi , Juan J. Alburquerque-Bejar , Montse Sanchez-Cespedes
Oncogene 38 ( 31) 5921 -5932
8
2019
A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Juan Sandoval , Jesus Mendez-Gonzalez , Ernest Nadal , Guoan Chen
Journal of Clinical Oncology 31 ( 32) 4140 -4147
279
2013
Determining the profiles and parameters for gene amplification testing of growth factor receptors in lung cancer.
Eva Pros , Sylvie Lantuejoul , Lydia Sanchez-Verde , Sandra D Castillo
International Journal of Cancer 133 ( 4) 898 -907
27
2013
Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
Pedro P. Medina , Octavio A. Romero , Takashi Kohno , Luis M. Montuenga
Human Mutation 29 ( 5) 617 -622
267
2008
A gene-alteration profile of human lung cancer cell lines†
Raquel Blanco , Reika Iwakawa , Moying Tang , Takashi Kohno
Human Mutation 30 ( 8) 1199 -1206
94
2009
Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors.
Salvador Rodriguez-Nieto , Andres Cañada , Eva Pros , Ana I. Pinto
Human Mutation 32 ( 2)
82
2011
The SOX family of genes in cancer development: biological relevance and opportunities for therapy
Sandra D Castillo , Montse Sanchez-Cespedes
Expert Opinion on Therapeutic Targets 16 ( 9) 903 -919
131
2012
Manel Esteller David Sidransky James Herman Octavio A. Romero-Ferraro Luis M. Montuenga William Westra Paola Parrella Maria Saigí Morguí Jen, Jin Ernest Nadal Stephen B. Baylin amaia lujambio Takashi Kohno Antonio Gomez, PhD Manuel SERRANO Esteban Ballestar Marina Pollan OR Marina Pollán OR Marina Pollan-Santamaria OR Marina Pollán-Santamaría Sebastián Morán Juan Cruz Cigudosa